Velarion · Company Intelligence
Compensation Brief
Fiscal year 2023 · Filings through 2026-04-29

Regulus Therapeutics (RGLS)

CEO Joseph Hagan was paid $2,575,123 in fiscal year 2023, ↑ up 91.7% from fiscal year 2022, the 25th percentile of its disclosed peer group (SEC filing 0001193125-24-102883 ↗): executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.

$2,575,123 ↑
Joseph Hagan total, FY2023
25th
CEO pay percentile vs peers
—
CEO-to-median pay ratio
99.25%
Say-on-pay support, latest vote

Track this company's pay every filing: join the Pro seat waitlist

Velarion Pro: every company page, peer tools and exports, one seat — $1,200/year

A confirmation now and one email when Pro opens, and nothing else. Privacy

Ask our research desk — $99, 24h, every figure cited to its filing.

Sample answer — “What is the CEO’s total compensation?”
- Joseph Hagan (Chief Executive Officer), FY2023 total compensation $2,575,123 (base salary $615,800) [exec_comp, SEC accession 0001193125-24-102883, filed 2024-04-19]

Answered within 24 hours, every figure cited to its SEC filing. If our database cannot answer your question, you are refunded automatically.

01

Summary Compensation Table — fiscal year 2023

Named executive officerSalaryBonusStock awardsOption awardsNon-equity incentivePension / NQDCAll otherTotal
Joseph Hagan$615,800$0$88,000$1,528,091$332,532$0$9,900$2,575,123
Chief Executive Officer
Christopher Aker387,700033,300475,845178,34209,9001,085,087
Senior Vice President and General Counsel
Cris Calsada390,000033,300455,674179,40009,9001,068,174
Chief Financial Officer

A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.

Three-year trend — total compensation per named executive

Named executive officerFY2023 totalFY2022 totalFY2021 totalΔ FY2022→2023
Joseph Hagan$2,575,123$1,343,238—↑ +1,231,885
Christopher Aker1,085,087651,543—↑ +433,544
Cris Calsada1,068,174627,619—↑ +440,555

Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.

You have just read Regulus Therapeutics's Summary Compensation Table. The whole free brief as a PDF, emailed now, with every figure cited — then a few short notes on the deeper RGLS reports.

We send the PDF right away, then up to three short notes. Reply “unsubscribe” to any of them, any time.

How we handle your data → Privacy

Companies that benchmark against RGLS
1 company names RGLS as a compensation peer

The list of companies that name RGLS as a peer is temporarily unavailable — recheck shortly.

01c

Board of directors

One page per director: the seat, the committees and the fee table, read for one person at a time.

DirectorRoleFY2023 total
Alice S. Huang, Ph.DIndependent Director$93,441
David Baltimore, Ph.DIndependent Director$95,441
Hugh Rosen, M.D., Ph.DIndependent Director$93,441
Jake R. NunnIndependent Director$97,441
Kathryn J. CollierIndependent Director$107,441
Pascale WitzIndependent Director$93,441
Preston S. Klassen, M.DDirector—
Stelios Papadopoulos, Ph.DChair of the Board$131,441
William H. Rastetter, Ph.DIndependent Director$99,441
02

Equity transactions since the proxy statement was filed

Every insider equity transaction reported on Form 4 after the 2023 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.

InsiderRoleTransaction dateCodeSharesPriceValueSecuritySource
Christopher AkerSr. VP & General Counsel2025-01-09A66,625$1$90,610CommonForm 4 ↗
Cris CalsadaChief Financial Officer2025-01-09A21,000127,300CommonForm 4 ↗
Preston KlassenDirector2025-01-09A30,000139,000CommonForm 4 ↗
Preston KlassenDirector2025-01-09A37,500151,000CommonForm 4 ↗
Christopher AkerSr. VP & General Counsel2025-01-09A17,500122,750CommonForm 4 ↗
Cris CalsadaChief Financial Officer2025-01-09A62,500185,000CommonForm 4 ↗
Joseph P. HaganDirector2025-01-09A62,000180,600CommonForm 4 ↗
Joseph P. HaganDirector2025-01-09A218,7501297,500CommonForm 4 ↗
Preston KlassenDirector2025-01-13D31,445139,721CommonForm 4 ↗
Cris CalsadaChief Financial Officer2025-01-13D38,716148,906CommonForm 4 ↗
Christopher AkerSr. VP & General Counsel2025-01-13D38,547148,693CommonForm 4 ↗
Joseph P. HaganDirector2025-01-13D115,2901145,634CommonForm 4 ↗
Cris CalsadaChief Financial Officer2025-01-14D5,08816,427CommonForm 4 ↗
Christopher AkerSr. VP & General Counsel2025-01-14D5,08816,427CommonForm 4 ↗
Joseph P. HaganDirector2025-01-14D11,764114,860CommonForm 4 ↗
Joseph P. HaganDirector2025-01-30A50,000154,260CommonForm 4 ↗
Cris CalsadaChief Financial Officer2025-01-30A562,50000Derivative, Class A CommonForm 4 ↗
David BaltimoreDirector2025-01-30A19,610120,787CommonForm 4 ↗
Preston KlassenDirector2025-01-30A675,00000Derivative, Class A CommonForm 4 ↗
Joseph P. HaganDirector2025-01-30A1,350,00000Derivative, Class A CommonForm 4 ↗
Christopher AkerSr. VP & General Counsel2025-01-30A487,50000Derivative, Class A CommonForm 4 ↗
William H. RastetterDirector2025-04-30A62,50000CommonForm 4 ↗
Hugh RosenDirector2025-04-30A62,50000CommonForm 4 ↗
Kathryn J. CollierDirector2025-04-30A62,50000CommonForm 4 ↗
Alice Shih-hou HuangDirector2025-04-30A62,50000CommonForm 4 ↗
David BaltimoreDirector2025-04-30A62,50000CommonForm 4 ↗
David BaltimoreDirector2025-04-30A62,50000CommonForm 4 ↗
Jake R. NunnDirector2025-04-30A62,50000CommonForm 4 ↗
Pascale WitzDirector2025-04-30A62,50000CommonForm 4 ↗
Alice Shih-hou HuangDirector2025-04-30A62,50000CommonForm 4 ↗
Stelios PapadopoulosDirector2025-04-30A62,50000CommonForm 4 ↗
Preston KlassenDirector2025-06-03A12,000895,852CommonForm 4 ↗
Kathryn J. CollierDirector2025-06-16A1,3961013,820CommonForm 4 ↗
Dividend-equivalent accruals2025-06-16—1,396——1 insider, 1 accrual row
Kathryn J. CollierDirector2025-06-17D2,32500Derivative, Class A CommonForm 4 ↗
Kathryn J. CollierDirector2025-06-17A2,325920,460CommonForm 4 ↗
Kathryn J. CollierDirector2025-06-17A2,6041025,780CommonForm 4 ↗
Kathryn J. CollierDirector2025-06-17D2,60400Derivative, Class A CommonForm 4 ↗
Cris CalsadaChief Financial Officer2025-06-25D375,000——Derivative, Class A CommonForm 4 ↗
Cris CalsadaChief Financial Officer2025-06-25D45,000——Derivative, Class A CommonForm 4 ↗
David BaltimoreDirector2025-06-25D30,000——Derivative, Class A CommonForm 4 ↗
Hugh RosenDirector2025-06-25D30,000——Derivative, Class A CommonForm 4 ↗
Stelios PapadopoulosDirector2025-06-25D2,325——Derivative, Class A CommonForm 4 ↗
Pascale WitzDirector2025-06-25D677——Derivative, Class A CommonForm 4 ↗
Pascale WitzDirector2025-06-25D30,000——Derivative, Class A CommonForm 4 ↗
Pascale WitzDirector2025-06-25D15,000——Derivative, Class A CommonForm 4 ↗
William H. RastetterDirector2025-06-25D44,264——CommonForm 4 ↗
Joseph P. HaganDirector2025-06-25D249,000——Derivative, Class A CommonForm 4 ↗
Alice Shih-hou HuangDirector2025-06-25D60,000——Derivative, Class A CommonForm 4 ↗
Hugh RosenDirector2025-06-25D2,325——Derivative, Class A CommonForm 4 ↗
David BaltimoreDirector2025-06-25D27,377——CommonForm 4 ↗
Alice Shih-hou HuangDirector2025-06-25D60,000——Derivative, Class A CommonForm 4 ↗
Alice Shih-hou HuangDirector2025-06-25D15,000——Derivative, Class A CommonForm 4 ↗
Alice Shih-hou HuangDirector2025-06-25D57,292——CommonForm 4 ↗
Alice Shih-hou HuangDirector2025-06-25D27,377——CommonForm 4 ↗
Alice Shih-hou HuangDirector2025-06-25D57,292——CommonForm 4 ↗
Alice Shih-hou HuangDirector2025-06-25D5,208——CommonForm 4 ↗
Jake R. NunnDirector2025-06-25D15,000——Derivative, Class A CommonForm 4 ↗
Jake R. NunnDirector2025-06-25D4,000——Derivative, Class A CommonForm 4 ↗
Stelios PapadopoulosDirector2025-06-25D60,000——Derivative, Class A CommonForm 4 ↗
Stelios PapadopoulosDirector2025-06-25D30,000——Derivative, Class A CommonForm 4 ↗
Stelios PapadopoulosDirector2025-06-25D15,000——Derivative, Class A CommonForm 4 ↗
Stelios PapadopoulosDirector2025-06-25D9,000——Derivative, Class A CommonForm 4 ↗
Stelios PapadopoulosDirector2025-06-25D64,635——CommonForm 4 ↗
Pascale WitzDirector2025-06-25D2,325——Derivative, Class A CommonForm 4 ↗
Pascale WitzDirector2025-06-25D4,650——Derivative, Class A CommonForm 4 ↗
William H. RastetterDirector2025-06-25D15,000——Derivative, Class A CommonForm 4 ↗
William H. RastetterDirector2025-06-25D30,000——Derivative, Class A CommonForm 4 ↗
William H. RastetterDirector2025-06-25D9,000——Derivative, Class A CommonForm 4 ↗
William H. RastetterDirector2025-06-25D4,650——Derivative, Class A CommonForm 4 ↗
Cris CalsadaChief Financial Officer2025-06-25D562,500——Derivative, Class A CommonForm 4 ↗
Cris CalsadaChief Financial Officer2025-06-25D462,000——Derivative, Class A CommonForm 4 ↗
Cris CalsadaChief Financial Officer2025-06-25D5,000——Derivative, Class A CommonForm 4 ↗
Cris CalsadaChief Financial Officer2025-06-25D48,000——Derivative, Class A CommonForm 4 ↗
Cris CalsadaChief Financial Officer2025-06-25D15,000——Derivative, Class A CommonForm 4 ↗
Cris CalsadaChief Financial Officer2025-06-25D10,000——Derivative, Class A CommonForm 4 ↗
Kathryn J. CollierDirector2025-06-25D60,000——Derivative, Class A CommonForm 4 ↗
Kathryn J. CollierDirector2025-06-25D30,000——Derivative, Class A CommonForm 4 ↗
Kathryn J. CollierDirector2025-06-25D4,650——Derivative, Class A CommonForm 4 ↗
Alice Shih-hou HuangDirector2025-06-25D9,000——Derivative, Class A CommonForm 4 ↗
Alice Shih-hou HuangDirector2025-06-25D4,000——Derivative, Class A CommonForm 4 ↗
Alice Shih-hou HuangDirector2025-06-25D4,650——Derivative, Class A CommonForm 4 ↗
Alice Shih-hou HuangDirector2025-06-25D30,000——Derivative, Class A CommonForm 4 ↗
Jake R. NunnDirector2025-06-25D9,000——Derivative, Class A CommonForm 4 ↗
Jake R. NunnDirector2025-06-25D4,650——Derivative, Class A CommonForm 4 ↗
Jake R. NunnDirector2025-06-25D62,500——CommonForm 4 ↗
David BaltimoreDirector2025-06-25D30,000——Derivative, Class A CommonForm 4 ↗
David BaltimoreDirector2025-06-25D4,000——Derivative, Class A CommonForm 4 ↗
David BaltimoreDirector2025-06-25D4,000——Derivative, Class A CommonForm 4 ↗
David BaltimoreDirector2025-06-25D4,650——Derivative, Class A CommonForm 4 ↗
David BaltimoreDirector2025-06-25D57,292——CommonForm 4 ↗
David BaltimoreDirector2025-06-25D5,208——CommonForm 4 ↗
Joseph P. HaganDirector2025-06-25D100,000——Derivative, Class A CommonForm 4 ↗
Joseph P. HaganDirector2025-06-25D30,000——Derivative, Class A CommonForm 4 ↗
Joseph P. HaganDirector2025-06-25D6,500——Derivative, Class A CommonForm 4 ↗
Joseph P. HaganDirector2025-06-25D571,558——CommonForm 4 ↗
Christopher AkerSr. VP & General Counsel2025-06-25D45,000——Derivative, Class A CommonForm 4 ↗
Christopher AkerSr. VP & General Counsel2025-06-25D7,000——Derivative, Class A CommonForm 4 ↗
Christopher AkerSr. VP & General Counsel2025-06-25D21,000——Derivative, Class A CommonForm 4 ↗
Christopher AkerSr. VP & General Counsel2025-06-25D33,500——Derivative, Class A CommonForm 4 ↗
Christopher AkerSr. VP & General Counsel2025-06-25D750——Derivative, Class A CommonForm 4 ↗
Christopher AkerSr. VP & General Counsel2025-06-25D2,500——Derivative, Class A CommonForm 4 ↗
Preston KlassenDirector2025-06-25D115,555——CommonForm 4 ↗
Hugh RosenDirector2025-06-25D60,000——Derivative, Class A CommonForm 4 ↗
Hugh RosenDirector2025-06-25D15,000——Derivative, Class A CommonForm 4 ↗
Hugh RosenDirector2025-06-25D6,979——CommonForm 4 ↗
William H. RastetterDirector2025-06-25D57,292——CommonForm 4 ↗
Jake R. NunnDirector2025-06-25D60,000——Derivative, Class A CommonForm 4 ↗
Jake R. NunnDirector2025-06-25D30,000——Derivative, Class A CommonForm 4 ↗
Christopher AkerSr. VP & General Counsel2025-06-25D487,500——Derivative, Class A CommonForm 4 ↗
Preston KlassenDirector2025-06-25D120,000——Derivative, Class A CommonForm 4 ↗
Stelios PapadopoulosDirector2025-06-25D30,000——Derivative, Class A CommonForm 4 ↗
Stelios PapadopoulosDirector2025-06-25D4,650——Derivative, Class A CommonForm 4 ↗
William H. RastetterDirector2025-06-25D60,000——Derivative, Class A CommonForm 4 ↗
Cris CalsadaChief Financial Officer2025-06-25D85,000——Derivative, Class A CommonForm 4 ↗
Kathryn J. CollierDirector2025-06-25D30,000——Derivative, Class A CommonForm 4 ↗
Kathryn J. CollierDirector2025-06-25D15,000——Derivative, Class A CommonForm 4 ↗
Joseph P. HaganDirector2025-06-25D2,976——Derivative, Class A CommonForm 4 ↗
Joseph P. HaganDirector2025-06-25D160,000——Derivative, Class A CommonForm 4 ↗
Joseph P. HaganDirector2025-06-25D100,000——Derivative, Class A CommonForm 4 ↗
Joseph P. HaganDirector2025-06-25D1,000——Derivative, Class A CommonForm 4 ↗
Joseph P. HaganDirector2025-06-25D1,350,000——Derivative, Class A CommonForm 4 ↗
Joseph P. HaganDirector2025-06-25D990,000——Derivative, Class A CommonForm 4 ↗
Joseph P. HaganDirector2025-06-25D1,312,500——Derivative, Class A CommonForm 4 ↗
Joseph P. HaganDirector2025-06-25D90,000——Derivative, Class A CommonForm 4 ↗
Pascale WitzDirector2025-06-25D60,000——Derivative, Class A CommonForm 4 ↗
Pascale WitzDirector2025-06-25D9,000——Derivative, Class A CommonForm 4 ↗
Pascale WitzDirector2025-06-25D4,000——Derivative, Class A CommonForm 4 ↗
Pascale WitzDirector2025-06-25D67,233——CommonForm 4 ↗
Pascale WitzDirector2025-06-25D30,000——Derivative, Class A CommonForm 4 ↗
Cris CalsadaChief Financial Officer2025-06-25D140,228——CommonForm 4 ↗
Alice Shih-hou HuangDirector2025-06-25D9,000——Derivative, Class A CommonForm 4 ↗
Jake R. NunnDirector2025-06-25D2,325——Derivative, Class A CommonForm 4 ↗
Christopher AkerSr. VP & General Counsel2025-06-25D393,750——Derivative, Class A CommonForm 4 ↗
Preston KlassenDirector2025-06-25D675,000——Derivative, Class A CommonForm 4 ↗
Hugh RosenDirector2025-06-25D4,000——Derivative, Class A CommonForm 4 ↗
Hugh RosenDirector2025-06-25D4,650——Derivative, Class A CommonForm 4 ↗
Stelios PapadopoulosDirector2025-06-25D4,000——Derivative, Class A CommonForm 4 ↗
William H. RastetterDirector2025-06-25D4,000——Derivative, Class A CommonForm 4 ↗
William H. RastetterDirector2025-06-25D2,325——Derivative, Class A CommonForm 4 ↗
David BaltimoreDirector2025-06-25D2,325——Derivative, Class A CommonForm 4 ↗
David BaltimoreDirector2025-06-25D57,292——CommonForm 4 ↗
Christopher AkerSr. VP & General Counsel2025-06-25D363,000——Derivative, Class A CommonForm 4 ↗
Christopher AkerSr. VP & General Counsel2025-06-25D70,000——Derivative, Class A CommonForm 4 ↗
Christopher AkerSr. VP & General Counsel2025-06-25D60,796——CommonForm 4 ↗
Preston KlassenDirector2025-06-25D528,000——Derivative, Class A CommonForm 4 ↗
Preston KlassenDirector2025-06-25D350,000——Derivative, Class A CommonForm 4 ↗
Hugh RosenDirector2025-06-25D30,000——Derivative, Class A CommonForm 4 ↗
Hugh RosenDirector2025-06-25D9,000——Derivative, Class A CommonForm 4 ↗
Hugh RosenDirector2025-06-25D57,292——CommonForm 4 ↗
Stelios PapadopoulosDirector2025-06-25D59,514——Derivative, Class A CommonForm 4 ↗
Stelios PapadopoulosDirector2025-06-25D976,253——CommonForm 4 ↗
William H. RastetterDirector2025-06-25D30,000——Derivative, Class A CommonForm 4 ↗
Cris CalsadaChief Financial Officer2025-06-25D21,000——Derivative, Class A CommonForm 4 ↗
Kathryn J. CollierDirector2025-06-25D9,000——Derivative, Class A CommonForm 4 ↗
Kathryn J. CollierDirector2025-06-25D75,565——CommonForm 4 ↗
Alice Shih-hou HuangDirector2025-06-25D30,000——Derivative, Class A CommonForm 4 ↗
Alice Shih-hou HuangDirector2025-06-25D30,000——Derivative, Class A CommonForm 4 ↗
Alice Shih-hou HuangDirector2025-06-25D2,325——Derivative, Class A CommonForm 4 ↗
Alice Shih-hou HuangDirector2025-06-25D15,000——Derivative, Class A CommonForm 4 ↗
Alice Shih-hou HuangDirector2025-06-25D30,000——Derivative, Class A CommonForm 4 ↗
Alice Shih-hou HuangDirector2025-06-25D4,000——Derivative, Class A CommonForm 4 ↗
Jake R. NunnDirector2025-06-25D30,000——Derivative, Class A CommonForm 4 ↗
David BaltimoreDirector2025-06-25D60,000——Derivative, Class A CommonForm 4 ↗
David BaltimoreDirector2025-06-25D15,000——Derivative, Class A CommonForm 4 ↗
David BaltimoreDirector2025-06-25D9,000——Derivative, Class A CommonForm 4 ↗
David BaltimoreDirector2025-06-25D60,000——Derivative, Class A CommonForm 4 ↗
David BaltimoreDirector2025-06-25D30,000——Derivative, Class A CommonForm 4 ↗
David BaltimoreDirector2025-06-25D15,000——Derivative, Class A CommonForm 4 ↗
David BaltimoreDirector2025-06-25D30,000——Derivative, Class A CommonForm 4 ↗
David BaltimoreDirector2025-06-25D9,000——Derivative, Class A CommonForm 4 ↗
Christopher AkerSr. VP & General Counsel2025-06-25D48,000——Derivative, Class A CommonForm 4 ↗
Christopher AkerSr. VP & General Counsel2025-06-25D83,125——CommonForm 4 ↗
Preston KlassenDirector2025-06-25D225,000——Derivative, Class A CommonForm 4 ↗

Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.

View all 174 transactions
InsiderRoleTransaction dateCodeSharesPriceValueSecuritySource
Christopher AkerSr. VP & General Counsel2025-01-09A66,625$1$90,610CommonForm 4 ↗
Cris CalsadaChief Financial Officer2025-01-09A21,000127,300CommonForm 4 ↗
Preston KlassenDirector2025-01-09A30,000139,000CommonForm 4 ↗
Preston KlassenDirector2025-01-09A37,500151,000CommonForm 4 ↗
Christopher AkerSr. VP & General Counsel2025-01-09A17,500122,750CommonForm 4 ↗
Cris CalsadaChief Financial Officer2025-01-09A62,500185,000CommonForm 4 ↗
Joseph P. HaganDirector2025-01-09A62,000180,600CommonForm 4 ↗
Joseph P. HaganDirector2025-01-09A218,7501297,500CommonForm 4 ↗
Preston KlassenDirector2025-01-13D31,445139,721CommonForm 4 ↗
Cris CalsadaChief Financial Officer2025-01-13D38,716148,906CommonForm 4 ↗
Christopher AkerSr. VP & General Counsel2025-01-13D38,547148,693CommonForm 4 ↗
Joseph P. HaganDirector2025-01-13D115,2901145,634CommonForm 4 ↗
Cris CalsadaChief Financial Officer2025-01-14D5,08816,427CommonForm 4 ↗
Christopher AkerSr. VP & General Counsel2025-01-14D5,08816,427CommonForm 4 ↗
Joseph P. HaganDirector2025-01-14D11,764114,860CommonForm 4 ↗
Joseph P. HaganDirector2025-01-30A50,000154,260CommonForm 4 ↗
Cris CalsadaChief Financial Officer2025-01-30A562,50000Derivative, Class A CommonForm 4 ↗
David BaltimoreDirector2025-01-30A19,610120,787CommonForm 4 ↗
Preston KlassenDirector2025-01-30A675,00000Derivative, Class A CommonForm 4 ↗
Joseph P. HaganDirector2025-01-30A1,350,00000Derivative, Class A CommonForm 4 ↗
Christopher AkerSr. VP & General Counsel2025-01-30A487,50000Derivative, Class A CommonForm 4 ↗
William H. RastetterDirector2025-04-30A62,50000CommonForm 4 ↗
Hugh RosenDirector2025-04-30A62,50000CommonForm 4 ↗
Kathryn J. CollierDirector2025-04-30A62,50000CommonForm 4 ↗
Alice Shih-hou HuangDirector2025-04-30A62,50000CommonForm 4 ↗
David BaltimoreDirector2025-04-30A62,50000CommonForm 4 ↗
David BaltimoreDirector2025-04-30A62,50000CommonForm 4 ↗
Jake R. NunnDirector2025-04-30A62,50000CommonForm 4 ↗
Pascale WitzDirector2025-04-30A62,50000CommonForm 4 ↗
Alice Shih-hou HuangDirector2025-04-30A62,50000CommonForm 4 ↗
Stelios PapadopoulosDirector2025-04-30A62,50000CommonForm 4 ↗
Preston KlassenDirector2025-06-03A12,000895,852CommonForm 4 ↗
Kathryn J. CollierDirector2025-06-16A1,3961013,820CommonForm 4 ↗
Kathryn J. CollierDirector2025-06-16D1,39600Derivative, Class A CommonForm 4 ↗
Kathryn J. CollierDirector2025-06-17D2,32500Derivative, Class A CommonForm 4 ↗
Kathryn J. CollierDirector2025-06-17A2,325920,460CommonForm 4 ↗
Kathryn J. CollierDirector2025-06-17A2,6041025,780CommonForm 4 ↗
Kathryn J. CollierDirector2025-06-17D2,60400Derivative, Class A CommonForm 4 ↗
Cris CalsadaChief Financial Officer2025-06-25D375,000——Derivative, Class A CommonForm 4 ↗
Cris CalsadaChief Financial Officer2025-06-25D45,000——Derivative, Class A CommonForm 4 ↗
David BaltimoreDirector2025-06-25D30,000——Derivative, Class A CommonForm 4 ↗
Hugh RosenDirector2025-06-25D30,000——Derivative, Class A CommonForm 4 ↗
Stelios PapadopoulosDirector2025-06-25D2,325——Derivative, Class A CommonForm 4 ↗
Pascale WitzDirector2025-06-25D677——Derivative, Class A CommonForm 4 ↗
Pascale WitzDirector2025-06-25D30,000——Derivative, Class A CommonForm 4 ↗
Pascale WitzDirector2025-06-25D15,000——Derivative, Class A CommonForm 4 ↗
William H. RastetterDirector2025-06-25D44,264——CommonForm 4 ↗
Joseph P. HaganDirector2025-06-25D249,000——Derivative, Class A CommonForm 4 ↗
Alice Shih-hou HuangDirector2025-06-25D60,000——Derivative, Class A CommonForm 4 ↗
Hugh RosenDirector2025-06-25D2,325——Derivative, Class A CommonForm 4 ↗
David BaltimoreDirector2025-06-25D27,377——CommonForm 4 ↗
Alice Shih-hou HuangDirector2025-06-25D60,000——Derivative, Class A CommonForm 4 ↗
Alice Shih-hou HuangDirector2025-06-25D15,000——Derivative, Class A CommonForm 4 ↗
Alice Shih-hou HuangDirector2025-06-25D57,292——CommonForm 4 ↗
Alice Shih-hou HuangDirector2025-06-25D27,377——CommonForm 4 ↗
Alice Shih-hou HuangDirector2025-06-25D57,292——CommonForm 4 ↗
Alice Shih-hou HuangDirector2025-06-25D5,208——CommonForm 4 ↗
Jake R. NunnDirector2025-06-25D15,000——Derivative, Class A CommonForm 4 ↗
Jake R. NunnDirector2025-06-25D4,000——Derivative, Class A CommonForm 4 ↗
Stelios PapadopoulosDirector2025-06-25D60,000——Derivative, Class A CommonForm 4 ↗
Stelios PapadopoulosDirector2025-06-25D30,000——Derivative, Class A CommonForm 4 ↗
Stelios PapadopoulosDirector2025-06-25D15,000——Derivative, Class A CommonForm 4 ↗
Stelios PapadopoulosDirector2025-06-25D9,000——Derivative, Class A CommonForm 4 ↗
Stelios PapadopoulosDirector2025-06-25D64,635——CommonForm 4 ↗
Pascale WitzDirector2025-06-25D2,325——Derivative, Class A CommonForm 4 ↗
Pascale WitzDirector2025-06-25D4,650——Derivative, Class A CommonForm 4 ↗
William H. RastetterDirector2025-06-25D15,000——Derivative, Class A CommonForm 4 ↗
William H. RastetterDirector2025-06-25D30,000——Derivative, Class A CommonForm 4 ↗
William H. RastetterDirector2025-06-25D9,000——Derivative, Class A CommonForm 4 ↗
William H. RastetterDirector2025-06-25D4,650——Derivative, Class A CommonForm 4 ↗
Cris CalsadaChief Financial Officer2025-06-25D562,500——Derivative, Class A CommonForm 4 ↗
Cris CalsadaChief Financial Officer2025-06-25D462,000——Derivative, Class A CommonForm 4 ↗
Cris CalsadaChief Financial Officer2025-06-25D5,000——Derivative, Class A CommonForm 4 ↗
Cris CalsadaChief Financial Officer2025-06-25D48,000——Derivative, Class A CommonForm 4 ↗
Cris CalsadaChief Financial Officer2025-06-25D15,000——Derivative, Class A CommonForm 4 ↗
Cris CalsadaChief Financial Officer2025-06-25D10,000——Derivative, Class A CommonForm 4 ↗
Kathryn J. CollierDirector2025-06-25D60,000——Derivative, Class A CommonForm 4 ↗
Kathryn J. CollierDirector2025-06-25D30,000——Derivative, Class A CommonForm 4 ↗
Kathryn J. CollierDirector2025-06-25D4,650——Derivative, Class A CommonForm 4 ↗
Alice Shih-hou HuangDirector2025-06-25D9,000——Derivative, Class A CommonForm 4 ↗
Alice Shih-hou HuangDirector2025-06-25D4,000——Derivative, Class A CommonForm 4 ↗
Alice Shih-hou HuangDirector2025-06-25D4,650——Derivative, Class A CommonForm 4 ↗
Alice Shih-hou HuangDirector2025-06-25D30,000——Derivative, Class A CommonForm 4 ↗
Jake R. NunnDirector2025-06-25D9,000——Derivative, Class A CommonForm 4 ↗
Jake R. NunnDirector2025-06-25D4,650——Derivative, Class A CommonForm 4 ↗
Jake R. NunnDirector2025-06-25D62,500——CommonForm 4 ↗
David BaltimoreDirector2025-06-25D30,000——Derivative, Class A CommonForm 4 ↗
David BaltimoreDirector2025-06-25D4,000——Derivative, Class A CommonForm 4 ↗
David BaltimoreDirector2025-06-25D4,000——Derivative, Class A CommonForm 4 ↗
David BaltimoreDirector2025-06-25D4,650——Derivative, Class A CommonForm 4 ↗
David BaltimoreDirector2025-06-25D57,292——CommonForm 4 ↗
David BaltimoreDirector2025-06-25D5,208——CommonForm 4 ↗
Joseph P. HaganDirector2025-06-25D100,000——Derivative, Class A CommonForm 4 ↗
Joseph P. HaganDirector2025-06-25D30,000——Derivative, Class A CommonForm 4 ↗
Joseph P. HaganDirector2025-06-25D6,500——Derivative, Class A CommonForm 4 ↗
Joseph P. HaganDirector2025-06-25D571,558——CommonForm 4 ↗
Christopher AkerSr. VP & General Counsel2025-06-25D45,000——Derivative, Class A CommonForm 4 ↗
Christopher AkerSr. VP & General Counsel2025-06-25D7,000——Derivative, Class A CommonForm 4 ↗
Christopher AkerSr. VP & General Counsel2025-06-25D21,000——Derivative, Class A CommonForm 4 ↗
Christopher AkerSr. VP & General Counsel2025-06-25D33,500——Derivative, Class A CommonForm 4 ↗
Christopher AkerSr. VP & General Counsel2025-06-25D750——Derivative, Class A CommonForm 4 ↗
Christopher AkerSr. VP & General Counsel2025-06-25D2,500——Derivative, Class A CommonForm 4 ↗
Preston KlassenDirector2025-06-25D115,555——CommonForm 4 ↗
Hugh RosenDirector2025-06-25D60,000——Derivative, Class A CommonForm 4 ↗
Hugh RosenDirector2025-06-25D15,000——Derivative, Class A CommonForm 4 ↗
Hugh RosenDirector2025-06-25D6,979——CommonForm 4 ↗
William H. RastetterDirector2025-06-25D57,292——CommonForm 4 ↗
Jake R. NunnDirector2025-06-25D60,000——Derivative, Class A CommonForm 4 ↗
Jake R. NunnDirector2025-06-25D30,000——Derivative, Class A CommonForm 4 ↗
Christopher AkerSr. VP & General Counsel2025-06-25D487,500——Derivative, Class A CommonForm 4 ↗
Preston KlassenDirector2025-06-25D120,000——Derivative, Class A CommonForm 4 ↗
Stelios PapadopoulosDirector2025-06-25D30,000——Derivative, Class A CommonForm 4 ↗
Stelios PapadopoulosDirector2025-06-25D4,650——Derivative, Class A CommonForm 4 ↗
William H. RastetterDirector2025-06-25D60,000——Derivative, Class A CommonForm 4 ↗
Cris CalsadaChief Financial Officer2025-06-25D85,000——Derivative, Class A CommonForm 4 ↗
Kathryn J. CollierDirector2025-06-25D30,000——Derivative, Class A CommonForm 4 ↗
Kathryn J. CollierDirector2025-06-25D15,000——Derivative, Class A CommonForm 4 ↗
Joseph P. HaganDirector2025-06-25D2,976——Derivative, Class A CommonForm 4 ↗
Joseph P. HaganDirector2025-06-25D160,000——Derivative, Class A CommonForm 4 ↗
Joseph P. HaganDirector2025-06-25D100,000——Derivative, Class A CommonForm 4 ↗
Joseph P. HaganDirector2025-06-25D1,000——Derivative, Class A CommonForm 4 ↗
Joseph P. HaganDirector2025-06-25D1,350,000——Derivative, Class A CommonForm 4 ↗
Joseph P. HaganDirector2025-06-25D990,000——Derivative, Class A CommonForm 4 ↗
Joseph P. HaganDirector2025-06-25D1,312,500——Derivative, Class A CommonForm 4 ↗
Joseph P. HaganDirector2025-06-25D90,000——Derivative, Class A CommonForm 4 ↗
Pascale WitzDirector2025-06-25D60,000——Derivative, Class A CommonForm 4 ↗
Pascale WitzDirector2025-06-25D9,000——Derivative, Class A CommonForm 4 ↗
Pascale WitzDirector2025-06-25D4,000——Derivative, Class A CommonForm 4 ↗
Pascale WitzDirector2025-06-25D67,233——CommonForm 4 ↗
Pascale WitzDirector2025-06-25D30,000——Derivative, Class A CommonForm 4 ↗
Cris CalsadaChief Financial Officer2025-06-25D140,228——CommonForm 4 ↗
Alice Shih-hou HuangDirector2025-06-25D9,000——Derivative, Class A CommonForm 4 ↗
Jake R. NunnDirector2025-06-25D2,325——Derivative, Class A CommonForm 4 ↗
Christopher AkerSr. VP & General Counsel2025-06-25D393,750——Derivative, Class A CommonForm 4 ↗
Preston KlassenDirector2025-06-25D675,000——Derivative, Class A CommonForm 4 ↗
Hugh RosenDirector2025-06-25D4,000——Derivative, Class A CommonForm 4 ↗
Hugh RosenDirector2025-06-25D4,650——Derivative, Class A CommonForm 4 ↗
Stelios PapadopoulosDirector2025-06-25D4,000——Derivative, Class A CommonForm 4 ↗
William H. RastetterDirector2025-06-25D4,000——Derivative, Class A CommonForm 4 ↗
William H. RastetterDirector2025-06-25D2,325——Derivative, Class A CommonForm 4 ↗
David BaltimoreDirector2025-06-25D2,325——Derivative, Class A CommonForm 4 ↗
David BaltimoreDirector2025-06-25D57,292——CommonForm 4 ↗
Christopher AkerSr. VP & General Counsel2025-06-25D363,000——Derivative, Class A CommonForm 4 ↗
Christopher AkerSr. VP & General Counsel2025-06-25D70,000——Derivative, Class A CommonForm 4 ↗
Christopher AkerSr. VP & General Counsel2025-06-25D60,796——CommonForm 4 ↗
Preston KlassenDirector2025-06-25D528,000——Derivative, Class A CommonForm 4 ↗
Preston KlassenDirector2025-06-25D350,000——Derivative, Class A CommonForm 4 ↗
Hugh RosenDirector2025-06-25D30,000——Derivative, Class A CommonForm 4 ↗
Hugh RosenDirector2025-06-25D9,000——Derivative, Class A CommonForm 4 ↗
Hugh RosenDirector2025-06-25D57,292——CommonForm 4 ↗
Stelios PapadopoulosDirector2025-06-25D59,514——Derivative, Class A CommonForm 4 ↗
Stelios PapadopoulosDirector2025-06-25D976,253——CommonForm 4 ↗
William H. RastetterDirector2025-06-25D30,000——Derivative, Class A CommonForm 4 ↗
Cris CalsadaChief Financial Officer2025-06-25D21,000——Derivative, Class A CommonForm 4 ↗
Kathryn J. CollierDirector2025-06-25D9,000——Derivative, Class A CommonForm 4 ↗
Kathryn J. CollierDirector2025-06-25D75,565——CommonForm 4 ↗
Alice Shih-hou HuangDirector2025-06-25D30,000——Derivative, Class A CommonForm 4 ↗
Alice Shih-hou HuangDirector2025-06-25D30,000——Derivative, Class A CommonForm 4 ↗
Alice Shih-hou HuangDirector2025-06-25D2,325——Derivative, Class A CommonForm 4 ↗
Alice Shih-hou HuangDirector2025-06-25D15,000——Derivative, Class A CommonForm 4 ↗
Alice Shih-hou HuangDirector2025-06-25D30,000——Derivative, Class A CommonForm 4 ↗
Alice Shih-hou HuangDirector2025-06-25D4,000——Derivative, Class A CommonForm 4 ↗
Jake R. NunnDirector2025-06-25D30,000——Derivative, Class A CommonForm 4 ↗
David BaltimoreDirector2025-06-25D60,000——Derivative, Class A CommonForm 4 ↗
David BaltimoreDirector2025-06-25D15,000——Derivative, Class A CommonForm 4 ↗
David BaltimoreDirector2025-06-25D9,000——Derivative, Class A CommonForm 4 ↗
David BaltimoreDirector2025-06-25D60,000——Derivative, Class A CommonForm 4 ↗
David BaltimoreDirector2025-06-25D30,000——Derivative, Class A CommonForm 4 ↗
David BaltimoreDirector2025-06-25D15,000——Derivative, Class A CommonForm 4 ↗
David BaltimoreDirector2025-06-25D30,000——Derivative, Class A CommonForm 4 ↗
David BaltimoreDirector2025-06-25D9,000——Derivative, Class A CommonForm 4 ↗
Christopher AkerSr. VP & General Counsel2025-06-25D48,000——Derivative, Class A CommonForm 4 ↗
Christopher AkerSr. VP & General Counsel2025-06-25D83,125——CommonForm 4 ↗
Preston KlassenDirector2025-06-25D225,000——Derivative, Class A CommonForm 4 ↗
04

Outstanding equity awards at fiscal year-end 2023

ExecutiveAwardShares unvestedExercise priceMarket value unvested
Joseph HaganPSU30,000—$38,400
Christopher AkerOption43713.1—
Christopher AkerPSU11,250—14,400
Joseph HaganOption29,99913.1—
Joseph HaganOption1,0009.5—
Christopher AkerOption7509.5—
Christopher AkerOption33,5006.4—
Christopher AkerOption4,87515.9—
Christopher AkerOption24,9972.6—
Christopher AkerOption34,6881.48—
Christopher AkerOption360,9381.36—
Cris CalsadaOption21,0006.4—
Cris CalsadaPSU11,250—14,400
Cris CalsadaOption24,9972.6—
Cris CalsadaOption31213.1—
Christopher AkerOption7,00013.1—
Cris CalsadaOption5,00013.1—
Joseph HaganOption77,0841.48—
Joseph HaganPSU437,500—560,000
Christopher AkerPSU131,250—168,000
Cris CalsadaPSU125,000—160,000
Joseph HaganOption6,5009.5—
Joseph HaganOption99,9996.4—
Joseph HaganOption1,87513.1—
Joseph HaganOption16,25015.9—
Joseph HaganOption83,3272.6—
Joseph HaganOption1,203,1261.36—
Christopher AkerOption2,5009.5—
Cris CalsadaOption10,0006.2—
Cris CalsadaOption4,05615.9—
Cris CalsadaOption24,6881.48—
Cris CalsadaOption343,7511.36—
05

Incentive-plan design — the Compensation Discussion & Analysis

Our executive compensation program is designed to reward achievement of the specific strategic goals that we believe will advance our business strategy and create long-term value for our stockholders. Consistent with our goal of attracting, motivating and retaining a high-caliber executive team, our executive compensation program is designed to pay for performance.

CEO STI target (% of salary)60%
CEO LTI target (% of salary)—
Independent consultantAon/Radford
Clawback policyTrue
Anti-hedgingTrue
Anti-pledgingTrue
06

Say-on-pay — recent advisory votes

Meeting yearMeeting dateForAgainstAbstainSupportOutcome
20242024-05-1638,219,586223,13966,21599.25%Passed
20232023-06-1312,652,198334,62832,96497.42%Passed
20222022-06-0974,847,7444,844,630563,72493.92%Passed
20212021-06-1432,643,5801,013,00081,79396.76%Passed
20202020-06-177,956,6012,107,96724,57479.06%Passed

Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.

Say-on-pay — history, company's computation

Meeting yearMeeting dateApproval — company's computation
20242024-05-1699.25%a
20232023-06-1397.42%b
20222022-06-0993.92%c

a. Approved under the standard stated in the filing — “Abstentions will be counted towards the vote total for Proposal 4 and will have the same effect as votes “Against” each of the proposed voting frequencies.”.

b. Voting standard not stated in the filing.

c. Voting standard not stated in the filing.

Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.

08

Director compensation — fiscal year 2023

DirectorCash feesStock awardsOption awardsNon-equity incentiveAll otherTotal
Stelios Papadopoulos, Ph.DIndependent · Board Chair · Nominating/Governance$84,000$0$47,441—$0$131,441
Kathryn J. CollierIndependent · Compensation (Chair)60,000047,441—0107,441
William H. Rastetter, Ph.DIndependent · Compensation52,000047,441—099,441
Jake R. NunnIndependent · Audit50,000047,441—097,441
David Baltimore, Ph.DIndependent · Nominating/Governance (Chair)48,000047,441—095,441
Pascale WitzIndependent · Audit46,000047,441—093,441
Hugh Rosen, M.D., Ph.DIndependent · Nominating/Governance46,000047,441—093,441
Alice S. Huang, Ph.DIndependent · Audit46,000047,441—093,441
Joseph P. HaganEmployee director000—00
Preston S. Klassen, M.DEmployee director000—00
09

Board fee structure and ownership guideline

Annual cash retainer$40,000
Annual equity retainer—
Per board meeting fee—
Committee chair fees (audit / comp / nom-gov)10,000 / 6,000 / 4,000
Stock ownership guideline—
09b

Total cost of the board

ComponentFY2023
Cash retainers and fees$432,000
Equity awards (grant-date value)$0
All other compensation$0
Total cost of the board$432,000

Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.

10

Disclosed peer group — fiscal year 2023

The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.

BCDA BioCardiaATYR aTyr Pharma ContraFectRZLT Rezolute TRACON Pharmaceuticals CohBar SynlogicCRVS Corvus PharmaceuticalsLCTX Lineage Cell Therapeutics OtonomyPULM Pulmatrix
10a

Peer reciprocity

Of the companies Regulus Therapeutics names as compensation peers, which name it back in their own disclosed peer groups. A peer set the market reciprocates reads differently from one selected in a single direction.

Reciprocity shown where the peer's own current proxy has been read — each mark is cited in the register to that peer's filing. A dash means the peer's current proxy was read and names no reciprocal group including Regulus Therapeutics.

10b

Chief executive pay against the peer group

Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.

RankCompanyFYChief executiveSalaryStock awardsOption awardsNon-equity incentiveTotal
1Corvus Pharmaceuticals2025Richard Miller$36,566$0$6,989,000$0$7,031,566
2aTyr Pharma2025Sanjay Shukla638,97702,595,200210,8623,456,253
3Rezolute2025Nevan Charles Elam610,8251,767,204002,851,109
4Regulus Therapeutics2023Joseph Hagan615,80088,0001,528,091332,5322,575,123
5Lineage Cell Therapeutics2025Brian Culley691,8000882,970518,9002,111,170
—BioCardia——————not in coverage universe
—Pulmatrix——————not in coverage universe

Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.

10c

Incentive design against the same peers

CompanyAnnual incentive payoutLong-term vehicle mixPSU measures include TSRCompensation consultant
Regulus Therapeuticsnot disclosednot disclosedNoAon/Radford
aTyr Pharma60% (Committee lowered payout from 75% achievement to 60% given EFZO-FIT study results)%Option 100not disclosedRadford
BioCardianot disclosednot disclosednot disclosednot disclosed
Corvus Pharmaceuticalsnot disclosedOption 100not disclosednot disclosed
Lineage Cell Therapeuticsnot disclosednot disclosednot disclosedAnderson
Pulmatrixnot disclosednot disclosednot disclosednot disclosed
Rezolutenot disclosednot disclosednot disclosednot disclosed

Read from each company's Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company's filing does not state the item.

10d

Frequently asked questions

Who was the highest-paid executive at Regulus Therapeutics in fiscal 2023?
As disclosed, Joseph Hagan (Chief Executive Officer) was the highest-paid executive at Regulus Therapeutics in fiscal 2023, with total compensation of $2,575,123.
How does Regulus Therapeutics's chief executive pay compare to its disclosed peer group?
As disclosed, Joseph Hagan's total compensation ranked at the 25th percentile of Regulus Therapeutics's disclosed peer group.
How did shareholders vote on Regulus Therapeutics's executive compensation?
As disclosed, 99.25% of shareholders supported Regulus Therapeutics's executive compensation in the latest say-on-pay vote.
How much does Regulus Therapeutics spend in total on board compensation for fiscal 2023?
As disclosed, Regulus Therapeutics reported total board compensation of $432,000 for fiscal 2023.

Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.

11

Source register

Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.

#SupportsDocumentFiledAccessionLocation in document
1Section 01, Joseph HaganDEF 14A2024-04-190001193125-24-102883Section “Summary Compensation Table”. As printed: 2,575,123. Filing ↗machine: t54 · r2 · c27 · span 187482–187491
2Section 01, Christopher AkerDEF 14A2024-04-190001193125-24-102883Section “Summary Compensation Table”. As printed: 1,085,087. Filing ↗machine: t54 · r5 · c27 · span 190505–190514
3Section 01, Cris CalsadaDEF 14A2024-04-190001193125-24-102883Section “Summary Compensation Table”. As printed: 1,068,174. Filing ↗machine: t54 · r8 · c27 · span 193527–193536
4Section 08, Stelios Papadopoulos, Ph.DDEF 14A2024-04-190001193125-24-102883Section “Director Compensation”. As printed: 131,441. Filing ↗machine: span 348693–348700
5Section 08, Kathryn J. CollierDEF 14A2024-04-190001193125-24-102883Section “Director Compensation”. As printed: 107,441. Filing ↗machine: t108 · r3 · c11 · span 346457–346464
6Section 08, William H. Rastetter, Ph.DDEF 14A2024-04-190001193125-24-102883Section “Director Compensation”. As printed: 99,441. Filing ↗machine: span 349435–349441
7Section 08, Jake R. NunnDEF 14A2024-04-190001193125-24-102883Section “Director Compensation”. As printed: 97,441. Filing ↗machine: t108 · r5 · c11 · span 347934–347940
8Section 08, David Baltimore, Ph.DDEF 14A2024-04-190001193125-24-102883Section “Director Compensation”. As printed: 95,441. Filing ↗machine: span 345725–345731
9Section 08, Pascale WitzDEF 14A2024-04-190001193125-24-102883Section “Director Compensation”. As printed: 93,441. Filing ↗machine: t108 · r9 · c11 · span 350916–350922
10Section 08, Hugh Rosen, M.D., Ph.DDEF 14A2024-04-190001193125-24-102883Section “Director Compensation”. As printed: 93,441. Filing ↗machine: span 350190–350196
11Section 08, Alice S. Huang, Ph.DDEF 14A2024-04-190001193125-24-102883Section “Director Compensation”. As printed: 93,441. Filing ↗machine: span 347211–347217
12Section 08, Joseph P. HaganDEF 14A2024-04-190001193125-24-102883Section “Director Compensation”. As printed: 0. Filing ↗
13Section 08, Preston S. Klassen, M.DDEF 14A2024-04-190001193125-24-102883Section “Director Compensation”. As printed: 0. Filing ↗
14Section 02, Christopher Aker 2025-01-09Form 42025-01-100000950170-25-004270Insider equity transaction reported since the proxy statement. Filing ↗
15Section 02, Cris Calsada 2025-01-09Form 42025-01-100000950170-25-004272Insider equity transaction reported since the proxy statement. Filing ↗
16Section 02, Preston Klassen 2025-01-09Form 42025-01-100000950170-25-004269Insider equity transaction reported since the proxy statement. Filing ↗
17Section 02, Preston Klassen 2025-01-09Form 42025-01-100000950170-25-004269Insider equity transaction reported since the proxy statement. Filing ↗
18Section 02, Christopher Aker 2025-01-09Form 42025-01-100000950170-25-004270Insider equity transaction reported since the proxy statement. Filing ↗
19Section 02, Cris Calsada 2025-01-09Form 42025-01-100000950170-25-004272Insider equity transaction reported since the proxy statement. Filing ↗
20Section 02, Joseph P. Hagan 2025-01-09Form 42025-01-100000950170-25-004274Insider equity transaction reported since the proxy statement. Filing ↗
21Section 02, Joseph P. Hagan 2025-01-09Form 42025-01-100000950170-25-004274Insider equity transaction reported since the proxy statement. Filing ↗
22Section 02, Preston Klassen 2025-01-13Form 42025-01-150000950170-25-005880Insider equity transaction reported since the proxy statement. Filing ↗
23Section 02, Cris Calsada 2025-01-13Form 42025-01-150000950170-25-005881Insider equity transaction reported since the proxy statement. Filing ↗
24Section 02, Christopher Aker 2025-01-13Form 42025-01-150000950170-25-005882Insider equity transaction reported since the proxy statement. Filing ↗
25Section 02, Joseph P. Hagan 2025-01-13Form 42025-01-150000950170-25-005883Insider equity transaction reported since the proxy statement. Filing ↗
26Section 02, Cris Calsada 2025-01-14Form 42025-01-150000950170-25-005881Insider equity transaction reported since the proxy statement. Filing ↗
27Section 02, Christopher Aker 2025-01-14Form 42025-01-150000950170-25-005882Insider equity transaction reported since the proxy statement. Filing ↗
28Section 02, Joseph P. Hagan 2025-01-14Form 42025-01-150000950170-25-005883Insider equity transaction reported since the proxy statement. Filing ↗
29Section 02, Joseph P. Hagan 2025-01-30Form 42025-01-310000950170-25-011853Insider equity transaction reported since the proxy statement. Filing ↗
30Section 02, Cris Calsada 2025-01-30Form 42025-01-310000950170-25-011848Insider equity transaction reported since the proxy statement. Filing ↗
31Section 02, David Baltimore 2025-01-30Form 42025-01-310000950170-25-011850Insider equity transaction reported since the proxy statement. Filing ↗
32Section 02, Preston Klassen 2025-01-30Form 42025-01-310000950170-25-011851Insider equity transaction reported since the proxy statement. Filing ↗
33Section 02, Joseph P. Hagan 2025-01-30Form 42025-01-310000950170-25-011853Insider equity transaction reported since the proxy statement. Filing ↗
34Section 02, Christopher Aker 2025-01-30Form 42025-01-310000950170-25-011849Insider equity transaction reported since the proxy statement. Filing ↗
35Section 02, William H. Rastetter 2025-04-30Form 42025-04-300000950170-25-061111Insider equity transaction reported since the proxy statement. Filing ↗
36Section 02, Hugh Rosen 2025-04-30Form 42025-04-300000950170-25-061113Insider equity transaction reported since the proxy statement. Filing ↗
37Section 02, Kathryn J. Collier 2025-04-30Form 42025-04-300000950170-25-061114Insider equity transaction reported since the proxy statement. Filing ↗
38Section 02, Alice Shih-hou Huang 2025-04-30Form 42025-04-300000950170-25-061117Insider equity transaction reported since the proxy statement. Filing ↗
39Section 02, David Baltimore 2025-04-30Form 42025-04-300000950170-25-061118Insider equity transaction reported since the proxy statement. Filing ↗
40Section 02, David Baltimore 2025-04-30Form 42025-04-300000950170-25-061118Insider equity transaction reported since the proxy statement. Filing ↗
41Section 02, Jake R. Nunn 2025-04-30Form 42025-04-300000950170-25-061298Insider equity transaction reported since the proxy statement. Filing ↗
42Section 02, Pascale Witz 2025-04-30Form 42025-04-300000950170-25-061115Insider equity transaction reported since the proxy statement. Filing ↗
43Section 02, Alice Shih-hou Huang 2025-04-30Form 42025-04-300000950170-25-061117Insider equity transaction reported since the proxy statement. Filing ↗
44Section 02, Stelios Papadopoulos 2025-04-30Form 42025-04-300000950170-25-061119Insider equity transaction reported since the proxy statement. Filing ↗
45Section 02, Preston Klassen 2025-06-03Form 42025-06-040000950170-25-081715Insider equity transaction reported since the proxy statement. Filing ↗
46Section 02, Kathryn J. Collier 2025-06-16Form 42025-06-180000950170-25-087947Insider equity transaction reported since the proxy statement. Filing ↗
47Section 02, Kathryn J. Collier 2025-06-16Form 42025-06-180000950170-25-087947Insider equity transaction reported since the proxy statement. Filing ↗
48Section 02, Kathryn J. Collier 2025-06-17Form 42025-06-180000950170-25-087947Insider equity transaction reported since the proxy statement. Filing ↗
49Section 02, Kathryn J. Collier 2025-06-17Form 42025-06-180000950170-25-087947Insider equity transaction reported since the proxy statement. Filing ↗
50Section 02, Kathryn J. Collier 2025-06-17Form 42025-06-180000950170-25-087947Insider equity transaction reported since the proxy statement. Filing ↗
51Section 02, Kathryn J. Collier 2025-06-17Form 42025-06-180000950170-25-087947Insider equity transaction reported since the proxy statement. Filing ↗
52Section 02, Cris Calsada 2025-06-25Form 42025-06-270000950170-25-090986Insider equity transaction reported since the proxy statement. Filing ↗
53Section 02, Cris Calsada 2025-06-25Form 42025-06-270000950170-25-090986Insider equity transaction reported since the proxy statement. Filing ↗
54Section 02, David Baltimore 2025-06-25Form 42025-06-270000950170-25-091008Insider equity transaction reported since the proxy statement. Filing ↗
55Section 02, Hugh Rosen 2025-06-25Form 42025-06-270000950170-25-091026Insider equity transaction reported since the proxy statement. Filing ↗
56Section 02, Stelios Papadopoulos 2025-06-25Form 42025-06-270000950170-25-091032Insider equity transaction reported since the proxy statement. Filing ↗
57Section 02, Pascale Witz 2025-06-25Form 42025-06-270000950170-25-091035Insider equity transaction reported since the proxy statement. Filing ↗
58Section 02, Pascale Witz 2025-06-25Form 42025-06-270000950170-25-091035Insider equity transaction reported since the proxy statement. Filing ↗
59Section 02, Pascale Witz 2025-06-25Form 42025-06-270000950170-25-091035Insider equity transaction reported since the proxy statement. Filing ↗
60Section 02, William H. Rastetter 2025-06-25Form 42025-06-270000950170-25-091036Insider equity transaction reported since the proxy statement. Filing ↗
61Section 02, Joseph P. Hagan 2025-06-25Form 42025-06-270000950170-25-091015Insider equity transaction reported since the proxy statement. Filing ↗
62Section 02, Alice Shih-hou Huang 2025-06-25Form 42025-06-270000950170-25-091003Insider equity transaction reported since the proxy statement. Filing ↗
63Section 02, Hugh Rosen 2025-06-25Form 42025-06-270000950170-25-091026Insider equity transaction reported since the proxy statement. Filing ↗
64Section 02, David Baltimore 2025-06-25Form 42025-06-270000950170-25-091008Insider equity transaction reported since the proxy statement. Filing ↗
65Section 02, Alice Shih-hou Huang 2025-06-25Form 42025-06-270000950170-25-091003Insider equity transaction reported since the proxy statement. Filing ↗
66Section 02, Alice Shih-hou Huang 2025-06-25Form 42025-06-270000950170-25-091003Insider equity transaction reported since the proxy statement. Filing ↗
67Section 02, Alice Shih-hou Huang 2025-06-25Form 42025-06-270000950170-25-091003Insider equity transaction reported since the proxy statement. Filing ↗
68Section 02, Alice Shih-hou Huang 2025-06-25Form 42025-06-270000950170-25-091003Insider equity transaction reported since the proxy statement. Filing ↗
69Section 02, Alice Shih-hou Huang 2025-06-25Form 42025-06-270000950170-25-091003Insider equity transaction reported since the proxy statement. Filing ↗
70Section 02, Alice Shih-hou Huang 2025-06-25Form 42025-06-270000950170-25-091003Insider equity transaction reported since the proxy statement. Filing ↗
71Section 02, Jake R. Nunn 2025-06-25Form 42025-06-270000950170-25-091006Insider equity transaction reported since the proxy statement. Filing ↗
72Section 02, Jake R. Nunn 2025-06-25Form 42025-06-270000950170-25-091006Insider equity transaction reported since the proxy statement. Filing ↗
73Section 02, Stelios Papadopoulos 2025-06-25Form 42025-06-270000950170-25-091032Insider equity transaction reported since the proxy statement. Filing ↗
74Section 02, Stelios Papadopoulos 2025-06-25Form 42025-06-270000950170-25-091032Insider equity transaction reported since the proxy statement. Filing ↗
75Section 02, Stelios Papadopoulos 2025-06-25Form 42025-06-270000950170-25-091032Insider equity transaction reported since the proxy statement. Filing ↗
76Section 02, Stelios Papadopoulos 2025-06-25Form 42025-06-270000950170-25-091032Insider equity transaction reported since the proxy statement. Filing ↗
77Section 02, Stelios Papadopoulos 2025-06-25Form 42025-06-270000950170-25-091032Insider equity transaction reported since the proxy statement. Filing ↗
78Section 02, Pascale Witz 2025-06-25Form 42025-06-270000950170-25-091035Insider equity transaction reported since the proxy statement. Filing ↗
79Section 02, Pascale Witz 2025-06-25Form 42025-06-270000950170-25-091035Insider equity transaction reported since the proxy statement. Filing ↗
80Section 02, William H. Rastetter 2025-06-25Form 42025-06-270000950170-25-091036Insider equity transaction reported since the proxy statement. Filing ↗
81Section 02, William H. Rastetter 2025-06-25Form 42025-06-270000950170-25-091036Insider equity transaction reported since the proxy statement. Filing ↗
82Section 02, William H. Rastetter 2025-06-25Form 42025-06-270000950170-25-091036Insider equity transaction reported since the proxy statement. Filing ↗
83Section 02, William H. Rastetter 2025-06-25Form 42025-06-270000950170-25-091036Insider equity transaction reported since the proxy statement. Filing ↗
84Section 02, Cris Calsada 2025-06-25Form 42025-06-270000950170-25-090986Insider equity transaction reported since the proxy statement. Filing ↗
85Section 02, Cris Calsada 2025-06-25Form 42025-06-270000950170-25-090986Insider equity transaction reported since the proxy statement. Filing ↗
86Section 02, Cris Calsada 2025-06-25Form 42025-06-270000950170-25-090986Insider equity transaction reported since the proxy statement. Filing ↗
87Section 02, Cris Calsada 2025-06-25Form 42025-06-270000950170-25-090986Insider equity transaction reported since the proxy statement. Filing ↗
88Section 02, Cris Calsada 2025-06-25Form 42025-06-270000950170-25-090986Insider equity transaction reported since the proxy statement. Filing ↗
89Section 02, Cris Calsada 2025-06-25Form 42025-06-270000950170-25-090986Insider equity transaction reported since the proxy statement. Filing ↗
90Section 02, Kathryn J. Collier 2025-06-25Form 42025-06-270000950170-25-090992Insider equity transaction reported since the proxy statement. Filing ↗
91Section 02, Kathryn J. Collier 2025-06-25Form 42025-06-270000950170-25-090992Insider equity transaction reported since the proxy statement. Filing ↗
92Section 02, Kathryn J. Collier 2025-06-25Form 42025-06-270000950170-25-090992Insider equity transaction reported since the proxy statement. Filing ↗
93Section 02, Alice Shih-hou Huang 2025-06-25Form 42025-06-270000950170-25-091003Insider equity transaction reported since the proxy statement. Filing ↗
94Section 02, Alice Shih-hou Huang 2025-06-25Form 42025-06-270000950170-25-091003Insider equity transaction reported since the proxy statement. Filing ↗
95Section 02, Alice Shih-hou Huang 2025-06-25Form 42025-06-270000950170-25-091003Insider equity transaction reported since the proxy statement. Filing ↗
96Section 02, Alice Shih-hou Huang 2025-06-25Form 42025-06-270000950170-25-091003Insider equity transaction reported since the proxy statement. Filing ↗
97Section 02, Jake R. Nunn 2025-06-25Form 42025-06-270000950170-25-091006Insider equity transaction reported since the proxy statement. Filing ↗
98Section 02, Jake R. Nunn 2025-06-25Form 42025-06-270000950170-25-091006Insider equity transaction reported since the proxy statement. Filing ↗
99Section 02, Jake R. Nunn 2025-06-25Form 42025-06-270000950170-25-091006Insider equity transaction reported since the proxy statement. Filing ↗
100Section 02, David Baltimore 2025-06-25Form 42025-06-270000950170-25-091008Insider equity transaction reported since the proxy statement. Filing ↗
101Section 02, David Baltimore 2025-06-25Form 42025-06-270000950170-25-091008Insider equity transaction reported since the proxy statement. Filing ↗
102Section 02, David Baltimore 2025-06-25Form 42025-06-270000950170-25-091008Insider equity transaction reported since the proxy statement. Filing ↗
103Section 02, David Baltimore 2025-06-25Form 42025-06-270000950170-25-091008Insider equity transaction reported since the proxy statement. Filing ↗
104Section 02, David Baltimore 2025-06-25Form 42025-06-270000950170-25-091008Insider equity transaction reported since the proxy statement. Filing ↗
105Section 02, David Baltimore 2025-06-25Form 42025-06-270000950170-25-091008Insider equity transaction reported since the proxy statement. Filing ↗
106Section 02, Joseph P. Hagan 2025-06-25Form 42025-06-270000950170-25-091015Insider equity transaction reported since the proxy statement. Filing ↗
107Section 02, Joseph P. Hagan 2025-06-25Form 42025-06-270000950170-25-091015Insider equity transaction reported since the proxy statement. Filing ↗
108Section 02, Joseph P. Hagan 2025-06-25Form 42025-06-270000950170-25-091015Insider equity transaction reported since the proxy statement. Filing ↗
109Section 02, Joseph P. Hagan 2025-06-25Form 42025-06-270000950170-25-091015Insider equity transaction reported since the proxy statement. Filing ↗
110Section 02, Christopher Aker 2025-06-25Form 42025-06-270000950170-25-091019Insider equity transaction reported since the proxy statement. Filing ↗
111Section 02, Christopher Aker 2025-06-25Form 42025-06-270000950170-25-091019Insider equity transaction reported since the proxy statement. Filing ↗
112Section 02, Christopher Aker 2025-06-25Form 42025-06-270000950170-25-091019Insider equity transaction reported since the proxy statement. Filing ↗
113Section 02, Christopher Aker 2025-06-25Form 42025-06-270000950170-25-091019Insider equity transaction reported since the proxy statement. Filing ↗
114Section 02, Christopher Aker 2025-06-25Form 42025-06-270000950170-25-091019Insider equity transaction reported since the proxy statement. Filing ↗
115Section 02, Christopher Aker 2025-06-25Form 42025-06-270000950170-25-091019Insider equity transaction reported since the proxy statement. Filing ↗
116Section 02, Preston Klassen 2025-06-25Form 42025-06-270000950170-25-091020Insider equity transaction reported since the proxy statement. Filing ↗
117Section 02, Hugh Rosen 2025-06-25Form 42025-06-270000950170-25-091026Insider equity transaction reported since the proxy statement. Filing ↗
118Section 02, Hugh Rosen 2025-06-25Form 42025-06-270000950170-25-091026Insider equity transaction reported since the proxy statement. Filing ↗
119Section 02, Hugh Rosen 2025-06-25Form 42025-06-270000950170-25-091026Insider equity transaction reported since the proxy statement. Filing ↗
120Section 02, William H. Rastetter 2025-06-25Form 42025-06-270000950170-25-091036Insider equity transaction reported since the proxy statement. Filing ↗
121Section 02, Jake R. Nunn 2025-06-25Form 42025-06-270000950170-25-091006Insider equity transaction reported since the proxy statement. Filing ↗
122Section 02, Jake R. Nunn 2025-06-25Form 42025-06-270000950170-25-091006Insider equity transaction reported since the proxy statement. Filing ↗
123Section 02, Christopher Aker 2025-06-25Form 42025-06-270000950170-25-091019Insider equity transaction reported since the proxy statement. Filing ↗
124Section 02, Preston Klassen 2025-06-25Form 42025-06-270000950170-25-091020Insider equity transaction reported since the proxy statement. Filing ↗
125Section 02, Stelios Papadopoulos 2025-06-25Form 42025-06-270000950170-25-091032Insider equity transaction reported since the proxy statement. Filing ↗
126Section 02, Stelios Papadopoulos 2025-06-25Form 42025-06-270000950170-25-091032Insider equity transaction reported since the proxy statement. Filing ↗
127Section 02, William H. Rastetter 2025-06-25Form 42025-06-270000950170-25-091036Insider equity transaction reported since the proxy statement. Filing ↗
128Section 02, Cris Calsada 2025-06-25Form 42025-06-270000950170-25-090986Insider equity transaction reported since the proxy statement. Filing ↗
129Section 02, Kathryn J. Collier 2025-06-25Form 42025-06-270000950170-25-090992Insider equity transaction reported since the proxy statement. Filing ↗
130Section 02, Kathryn J. Collier 2025-06-25Form 42025-06-270000950170-25-090992Insider equity transaction reported since the proxy statement. Filing ↗
131Section 02, Joseph P. Hagan 2025-06-25Form 42025-06-270000950170-25-091015Insider equity transaction reported since the proxy statement. Filing ↗
132Section 02, Joseph P. Hagan 2025-06-25Form 42025-06-270000950170-25-091015Insider equity transaction reported since the proxy statement. Filing ↗
133Section 02, Joseph P. Hagan 2025-06-25Form 42025-06-270000950170-25-091015Insider equity transaction reported since the proxy statement. Filing ↗
134Section 02, Joseph P. Hagan 2025-06-25Form 42025-06-270000950170-25-091015Insider equity transaction reported since the proxy statement. Filing ↗
135Section 02, Joseph P. Hagan 2025-06-25Form 42025-06-270000950170-25-091015Insider equity transaction reported since the proxy statement. Filing ↗
136Section 02, Joseph P. Hagan 2025-06-25Form 42025-06-270000950170-25-091015Insider equity transaction reported since the proxy statement. Filing ↗
137Section 02, Joseph P. Hagan 2025-06-25Form 42025-06-270000950170-25-091015Insider equity transaction reported since the proxy statement. Filing ↗
138Section 02, Joseph P. Hagan 2025-06-25Form 42025-06-270000950170-25-091015Insider equity transaction reported since the proxy statement. Filing ↗
139Section 02, Pascale Witz 2025-06-25Form 42025-06-270000950170-25-091035Insider equity transaction reported since the proxy statement. Filing ↗
140Section 02, Pascale Witz 2025-06-25Form 42025-06-270000950170-25-091035Insider equity transaction reported since the proxy statement. Filing ↗
141Section 02, Pascale Witz 2025-06-25Form 42025-06-270000950170-25-091035Insider equity transaction reported since the proxy statement. Filing ↗
142Section 02, Pascale Witz 2025-06-25Form 42025-06-270000950170-25-091035Insider equity transaction reported since the proxy statement. Filing ↗
143Section 02, Pascale Witz 2025-06-25Form 42025-06-270000950170-25-091035Insider equity transaction reported since the proxy statement. Filing ↗
144Section 02, Cris Calsada 2025-06-25Form 42025-06-270000950170-25-090986Insider equity transaction reported since the proxy statement. Filing ↗
145Section 02, Alice Shih-hou Huang 2025-06-25Form 42025-06-270000950170-25-091003Insider equity transaction reported since the proxy statement. Filing ↗
146Section 02, Jake R. Nunn 2025-06-25Form 42025-06-270000950170-25-091006Insider equity transaction reported since the proxy statement. Filing ↗
147Section 02, Christopher Aker 2025-06-25Form 42025-06-270000950170-25-091019Insider equity transaction reported since the proxy statement. Filing ↗
148Section 02, Preston Klassen 2025-06-25Form 42025-06-270000950170-25-091020Insider equity transaction reported since the proxy statement. Filing ↗
149Section 02, Hugh Rosen 2025-06-25Form 42025-06-270000950170-25-091026Insider equity transaction reported since the proxy statement. Filing ↗
150Section 02, Hugh Rosen 2025-06-25Form 42025-06-270000950170-25-091026Insider equity transaction reported since the proxy statement. Filing ↗
151Section 02, Stelios Papadopoulos 2025-06-25Form 42025-06-270000950170-25-091032Insider equity transaction reported since the proxy statement. Filing ↗
152Section 02, William H. Rastetter 2025-06-25Form 42025-06-270000950170-25-091036Insider equity transaction reported since the proxy statement. Filing ↗
153Section 02, William H. Rastetter 2025-06-25Form 42025-06-270000950170-25-091036Insider equity transaction reported since the proxy statement. Filing ↗
154Section 02, David Baltimore 2025-06-25Form 42025-06-270000950170-25-091008Insider equity transaction reported since the proxy statement. Filing ↗
155Section 02, David Baltimore 2025-06-25Form 42025-06-270000950170-25-091008Insider equity transaction reported since the proxy statement. Filing ↗
156Section 02, Christopher Aker 2025-06-25Form 42025-06-270000950170-25-091019Insider equity transaction reported since the proxy statement. Filing ↗
157Section 02, Christopher Aker 2025-06-25Form 42025-06-270000950170-25-091019Insider equity transaction reported since the proxy statement. Filing ↗
158Section 02, Christopher Aker 2025-06-25Form 42025-06-270000950170-25-091019Insider equity transaction reported since the proxy statement. Filing ↗
159Section 02, Preston Klassen 2025-06-25Form 42025-06-270000950170-25-091020Insider equity transaction reported since the proxy statement. Filing ↗
160Section 02, Preston Klassen 2025-06-25Form 42025-06-270000950170-25-091020Insider equity transaction reported since the proxy statement. Filing ↗
161Section 02, Hugh Rosen 2025-06-25Form 42025-06-270000950170-25-091026Insider equity transaction reported since the proxy statement. Filing ↗
162Section 02, Hugh Rosen 2025-06-25Form 42025-06-270000950170-25-091026Insider equity transaction reported since the proxy statement. Filing ↗
163Section 02, Hugh Rosen 2025-06-25Form 42025-06-270000950170-25-091026Insider equity transaction reported since the proxy statement. Filing ↗
164Section 02, Stelios Papadopoulos 2025-06-25Form 42025-06-270000950170-25-091032Insider equity transaction reported since the proxy statement. Filing ↗
165Section 02, Stelios Papadopoulos 2025-06-25Form 42025-06-270000950170-25-091032Insider equity transaction reported since the proxy statement. Filing ↗
166Section 02, William H. Rastetter 2025-06-25Form 42025-06-270000950170-25-091036Insider equity transaction reported since the proxy statement. Filing ↗
167Section 02, Cris Calsada 2025-06-25Form 42025-06-270000950170-25-090986Insider equity transaction reported since the proxy statement. Filing ↗
168Section 02, Kathryn J. Collier 2025-06-25Form 42025-06-270000950170-25-090992Insider equity transaction reported since the proxy statement. Filing ↗
169Section 02, Kathryn J. Collier 2025-06-25Form 42025-06-270000950170-25-090992Insider equity transaction reported since the proxy statement. Filing ↗
170Section 02, Alice Shih-hou Huang 2025-06-25Form 42025-06-270000950170-25-091003Insider equity transaction reported since the proxy statement. Filing ↗
171Section 02, Alice Shih-hou Huang 2025-06-25Form 42025-06-270000950170-25-091003Insider equity transaction reported since the proxy statement. Filing ↗
172Section 02, Alice Shih-hou Huang 2025-06-25Form 42025-06-270000950170-25-091003Insider equity transaction reported since the proxy statement. Filing ↗
173Section 02, Alice Shih-hou Huang 2025-06-25Form 42025-06-270000950170-25-091003Insider equity transaction reported since the proxy statement. Filing ↗
174Section 02, Alice Shih-hou Huang 2025-06-25Form 42025-06-270000950170-25-091003Insider equity transaction reported since the proxy statement. Filing ↗
175Section 02, Alice Shih-hou Huang 2025-06-25Form 42025-06-270000950170-25-091003Insider equity transaction reported since the proxy statement. Filing ↗
176Section 02, Jake R. Nunn 2025-06-25Form 42025-06-270000950170-25-091006Insider equity transaction reported since the proxy statement. Filing ↗
177Section 02, David Baltimore 2025-06-25Form 42025-06-270000950170-25-091008Insider equity transaction reported since the proxy statement. Filing ↗
178Section 02, David Baltimore 2025-06-25Form 42025-06-270000950170-25-091008Insider equity transaction reported since the proxy statement. Filing ↗
179Section 02, David Baltimore 2025-06-25Form 42025-06-270000950170-25-091008Insider equity transaction reported since the proxy statement. Filing ↗
180Section 02, David Baltimore 2025-06-25Form 42025-06-270000950170-25-091008Insider equity transaction reported since the proxy statement. Filing ↗
181Section 02, David Baltimore 2025-06-25Form 42025-06-270000950170-25-091008Insider equity transaction reported since the proxy statement. Filing ↗
182Section 02, David Baltimore 2025-06-25Form 42025-06-270000950170-25-091008Insider equity transaction reported since the proxy statement. Filing ↗
183Section 02, David Baltimore 2025-06-25Form 42025-06-270000950170-25-091008Insider equity transaction reported since the proxy statement. Filing ↗
184Section 02, David Baltimore 2025-06-25Form 42025-06-270000950170-25-091008Insider equity transaction reported since the proxy statement. Filing ↗
185Section 02, Christopher Aker 2025-06-25Form 42025-06-270000950170-25-091019Insider equity transaction reported since the proxy statement. Filing ↗
186Section 02, Christopher Aker 2025-06-25Form 42025-06-270000950170-25-091019Insider equity transaction reported since the proxy statement. Filing ↗
187Section 02, Preston Klassen 2025-06-25Form 42025-06-270000950170-25-091020Insider equity transaction reported since the proxy statement. Filing ↗
188Section 06, 2024 voteForm 8-K2024-05-170001193125-24-141703Item 5.07 · say-on-pay result. As reported: 99.25% (votes for as printed: 38,219,586). Filing ↗
189Section 06, 2023 voteForm 8-K2023-06-140001193125-23-166837Item 5.07 · say-on-pay result. As reported: 97.42% (votes for as printed: 12,652,198). Filing ↗
190Section 06, 2022 voteForm 8-K2022-06-130001193125-22-172905Item 5.07 · say-on-pay result. As reported: 93.92%. Filing ↗
191Section 01 trend, Δ column (computed)Computed——Δ = current-FY total − prior-FY total per named officer.machine: formula: Δ = FY(n) − FY(n−1)
192Section 09b board cost (computed)Computed——Cash 432,000 + equity 0 + all other 0 = 432,000, summed across the director compensation table rows.machine: formula: Σ = 432,000
193Corvus Pharmaceuticals, Section 10b CEO totalDEF 14A2026-04-240001104659-26-048595CEO total compensation as printed in Corvus Pharmaceuticals's own proxy. As printed: 7,031,566. Filing ↗
194aTyr Pharma, Section 10b CEO totalDEF 14A2026-03-260001339970-26-000021CEO total compensation as printed in aTyr Pharma's own proxy. As printed: 3,456,253. Filing ↗machine: r2 · c21 · span 533754–533763
195Rezolute, Section 10b CEO totalDEF 14A2025-10-070001104659-25-097509CEO total compensation as printed in Rezolute's own proxy. As printed: 2,851,109. Filing ↗
196Regulus Therapeutics (subject), Section 10b CEO totalDEF 14A2024-04-190001193125-24-102883CEO total compensation as printed in Regulus Therapeutics's own proxy. As printed: 2,575,123. Filing ↗machine: t54 · r2 · c27 · span 187482–187491
197Lineage Cell Therapeutics, Section 10b CEO totalDEF 14A2026-04-290001193125-26-191556CEO total compensation as printed in Lineage Cell Therapeutics's own proxy. As printed: 2,111,170. Filing ↗machine: span 377951–377960
198Section 10a, aTyr Pharma reciprocityDEF 14A—0001339970-26-000021aTyr Pharma's most recent proxy was read; its disclosed peer group does not include Regulus Therapeutics. Filing ↗
199Section 10a, Lineage Cell Therapeutics reciprocityDEF 14A—0001193125-26-191556Lineage Cell Therapeutics's most recent proxy was read; its disclosed peer group does not include Regulus Therapeutics. Filing ↗

The Pay Desk — the free weekly executive pay briefing, one company at a time, every number traceable to a public filing.

You'll confirm on The Pay Desk's sign-up page.